Work

042 Tumor neoantigens and a novel hapten vaccine promote immune targeting of wild type tumor antigens and improve response to immune checkpoint blockade

Year: 2020

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2020.03.044

Authors: M. Su, T. Erlich, J. Lo, M. LaFleur, M. Salomon, L. Kemeny, D. Hoon, G. Freeman, A. Sharpe, D. Fisher

Institution: Massachusetts General Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2995928479

FWCI:

Cites:

Cited by:

Related to: 10